Peripheral venous route for administration of ammonul infusion for treatment of acute hyperammonemia

References

1. ↵
   1. Alfadhel M,
   2. Al Mutairi F,
   3. Makhseed N,
   4. Al Jasmi F,
   5. Al-Thihli K,
   6. Al-Jishi E,
   7. et al.

   (2016) Guidelines for acute management of hyperammonemia in the Middle East region. Ther Clin Risk Manag 12:479–487.

   OpenUrl
2. ↵
   1. Adam MP,
   2. Ardinger HH,
   3. Pagon RA,
   4. Wallace SE,
   5. Bean LJH,
   6. Stephens K,
   7. Amemiya A

   1. Ah Mew N,
   2. Simpson KL,
   3. Gropman AL,
   4. Lanpher BC,
   5. Chapman KA,
   6. Summar ML

   in Source GeneReviews®[Internet], Urea cycle disorders overview, eds Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Stephens K, Amemiya A (University of Washington, Seattle, Seattle (WA)), pp 1993–2019.
3. ↵
   1. Scriver C,
   2. Beaudet A,
   3. Sly W,
   4. Valle D

   1. Brusilow S,
   2. Horwich A

   (2001) in The metabolic &molecular bases of inherited disease, Urea cycle enzymes, eds Scriver C, Beaudet A, Sly W, Valle D (McGraw-Hill, New York (NY)), 8th ed, pp 1909–1963.
4. ↵
   1. Summar ML,
   2. Mew NA

   (2018) Inborn Errors of Metabolism with Hyperammonemia:Urea cycle defects and related disorders. Pediatr Clin North Am 65:231–246.

   OpenUrl
5. ↵
   1. Ah Mew N,
   2. Krivitzky L,
   3. McCarter R,
   4. Batshaw M,
   5. Tuchman M

   (2013) Urea Cycle Disorders Consortium of the Rare Diseases Clinical Research Network. Clinical outcomes of neonatal onset proximal versus distal urea cycle disorders do not differ. J Pediatr 162:324–329, e1.

   OpenUrl
6. ↵
   1. Häberle J,
   2. Boddaert N,
   3. Burlina A,
   4. Chakrapani A,
   5. Dixon M,
   6. Huemer M,
   7. et al.

   (2012) Suggested guidelines for the diagnosis and management of urea cycle disorders. Orphanet J Rare Dis 7:32.

   OpenUrlCrossRefPubMed
7. ↵
   1. Hediger N,
   2. Landolt MA,
   3. Diez-Fernandez C,
   4. Huemer M,
   5. Häberle J

   (2018) The impact of ammonia levels and dialysis on outcome in 202 patients with neonatal-onset urea cycle disorders. J Inherit Metab Dis 41:689–698.

   OpenUrl
8. ↵
   1. Wilna Y,
   2. Blumenfeld YJ,
   3. Cusmano K,
   4. Hintz SR,
   5. Alcorn D,
   6. Benitz WE,
   7. et al.

   (2018) Prenatal treatment of ornithine transcarbamylase deficiency. Mol Genet Metab 123:297–300.

   OpenUrl
9. ↵
   1. Brossier D,
   2. Goyer I,
   3. Ziani L,
   4. etalBrossier D,
   5. Goyer I,
   6. Ziani L,
   7. Marquis C,
   8. Mitchell G,
   9. Ozanne B,
   10. et al.

   (2019) (2018) Influence of implementing a protocol for an intravenously administered ammonia scavenger on the management of acute hyperammonemia in a pediatric intensive care unit. J Inherit Metab Dis 42:77–85.

   OpenUrl
10. ↵
    1. Al-Asmari A,
    2. Al-Makadma A

    (2012) Atypical presentations of propionic acidemia. Health 4:629–633.

    OpenUrl
11. ↵
    1. Chapman KA,
    2. Gramer G,
    3. Viall S,
    4. Summar ML

    (2018) The incidence of maple syrup urine disease, propionic acidemia, and methylmalonic aciduria from newborn screening data. Mol Genet Metab Rep 5:106–109.

    OpenUrl
12. ↵
    1. Imtiaz F,
    2. Al-Mubarak BM,
    3. Al-Mostafa A,
    4. Al-Hamed M,
    5. Allam R,
    6. Al-Hassan Z,
    7. et al.

    (2016) The spectrum of mutations in 60 Saudi patients with MUT methylmalonic acidemia. JIMD 29:39–46.

    OpenUrl
13. ↵
    1. Al-Hamed MH,
    2. Imtiaz F,
    3. Al-Hassan Z,
    4. Al-Owain M,
    5. Al-Zaidan H,
    6. Alamoudi MS,
    7. et al.

    (2019) The spectrum of mutations underlying propionic acidemia and further insight into a genotype-phenotype correlation for the common mutation in Saudi Arabia. Mol Genet Metab Rep 18:22–29.

    OpenUrl
14. ↵
    1. Rafique M

    (2013) Clinical spectrum of propionic acidemia. J Nutr Metab 2013:975964.

    OpenUrl